The association between MYCN (MYCN Proto-Oncogene, BHLH Transcription Factor) and Familial Retinoblastoma is a manually-curated gene–disease association, supported by a single expert-curated source.
Sources1
Clinical variants0
Symptoms0
Compounds3
Trials27of 4,757 via MYCN compounds
Publications2
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.